ArticleBreast cancer research and treatment2020

Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer.

Jennifer R Diamond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.